Whole-Body Composition Features by Computed Tomography in Ovarian Cancer: Pilot Data on Survival Correlations
Cancers · 04.05.2023 · 15 (9) · 2602
DOI: 10.3390/cancers15092602 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 04.05.2023. Verfasst von Giorgio Raia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Istituto di Imaging della Svizzera Italiana (IIMSI), Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The primary objective of this study was to assess the associations of computed tomography (CT)-based whole-body composition values with overall survival (OS) and progression-free survival (PFS) in epithelial ovarian cancer (EOC) patients. The secondary objective was the association of body composition with chemotherapy-related toxicity.
Methods
Thirty-four patients (median age 64.9 years; interquartile range 55.4–75.4) with EOC and thorax and abdomen CT scans were included. Clinical data recorded: age; weight; height; stage; chemotherapy-related toxicity; and date of last contact, progression and death. Automatic extraction of body composition values was performed by dedicated software. Sarcopenia was defined according to predefined cutoffs. Statistical analysis included univariate tests to investigate associations of sarcopenia and body composition with chemotoxicity. Association of body composition parameters and OS/PFS was evaluated by log-rank test and Cox proportional hazard model. Multivariate models were adjusted for FIGO stage and/or age at diagnosis.
Results
We found significant associations of skeletal muscle volume with OS (p = 0.04) and PFS (p = 0.04); intramuscular fat volume with PFS (p = 0.03); and visceral adipose tissue, epicardial and paracardial fat with PFS (p = 0.04, 0.01 and 0.02, respectively). We found no significant associations between body composition parameters and chemotherapy-related toxicity.
Conclusions
In this exploratory study, we found significant associations of whole-body composition parameters with OS and PFS. These results open a window to the possibility to perform body composition profiling without approximate estimations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Istituto di Imaging della Svizzera Italiana (IIMSI), Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.
- Service of Medical Oncology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.
- Department of Radiological, Oncological and Pathological Sciences, University of Rome Sapienza (IT), 00185 Roma, Italy.
- Department of Gynecology and Obstetrics, Ente Ospedaliero Cantonale of Lugano (EOC), 6900 Lugano, Switzerland.
- Facoltà di Scienze Biomediche, Università della Svizzera Italiana, 6900 Lugano, Switzerland.
ORCID-Profile: Giorgio Raia, Maria Del Grande, Ilaria Colombo, Lucia Manganaro, Filippo Del Grande, Stefania Rizzo
Zitieren
APA
Raia, G., Del Grande, M., Colombo, I., Nerone, M., Manganaro, L., Gasparri, M. L., Papadia, A., Del Grande, F., & Rizzo, S. (2023). Whole-Body Composition Features by Computed Tomography in Ovarian Cancer: Pilot Data on Survival Correlations. Cancers, 15(9), 2602. https://doi.org/10.3390/cancers15092602
Vancouver
Raia G, Del Grande M, Colombo I, Nerone M, Manganaro L, Gasparri ML, et al. Whole-Body Composition Features by Computed Tomography in Ovarian Cancer: Pilot Data on Survival Correlations. Cancers. 2023;15(9):2602. doi:10.3390/cancers15092602
BibTeX
@article{Raia2023,
author = {Raia, Giorgio and Del Grande, Maria and Colombo, Ilaria and Nerone, Marta and Manganaro, Lucia and Gasparri, Maria Luisa and Papadia, Andrea and Del Grande, Filippo and Rizzo, Stefania},
title = {Whole-Body Composition Features by Computed Tomography in Ovarian Cancer: Pilot Data on Survival Correlations},
journal = {Cancers},
year = {2023},
volume = {15},
number = {9},
pages = {2602},
doi = {10.3390/cancers15092602}
}
EUVIMED